Difference between revisions of "Frolik CA, et al. Proc. Natl Acad. Sci. USA (1983) cited as Ref 339 in DOI: 10.1038/s41392-020-0110-5 (Q9602)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 3676-3680, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Smith DM, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Smith DM | ||
| Property / Fourth Author string: Smith DM / rank | |||
| + | Normal rank | ||
Revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Frolik CA, et al. Proc. Natl Acad. Sci. USA (1983) cited as Ref 339 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Frolik CA
0 references
Dart LL
0 references
Meyers CA
0 references
1983
0 references
Proc. Natl Acad. Sci. USA
0 references
80
0 references
Purification and initial characterization of a type beta transforming growth factor from human placenta (English)
0 references
3676-3680
0 references
Smith DM
0 references
